2013 promises more delay and infighting over the role of Brussels in European research and innovation. Our pledge: To keep up the pressure for a speedy resolution to disputes over future R&D funding
This week TiGenix reported positive safety data for its stem cell therapy for rheumatoid arthritis. The news highlights the potential of regenerative medicine as Science|Business publishes a special report examining how Europe can build on its leading position in this fast-paced field of research
Report of a high-level academic policy debate on resource innovation, containing key ideas and recommendations on how to manage scarce resources and energy in Europe.
Europe is currently a world leader in the fundamental science underpinning regenerative medicine and cell therapy, and in its therapeutic use and regulation. But how can Europe build on its leading position?
The proposed €80B Horizon 2020 programme should give greater weight to mission-driven, problem-solving research, and to post-research development concludes a new study published by EARTO, the European Association of Research and Technology Organisations
After more than four decades of negotiation, impasse and posturing, 25 member states agree to create a unitary patent. MEPs who voted for the move promise simplification, lower costs and time-saving for hard-pressed SMEs.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.